Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?

Nature Clinical Practice Cardiovascular Medicine volume 1, pages 10–11 (2004)Cite this article

boxed-textBristow MR et al. (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350: 2140–2150

CRT devices appear as effective as combined CRT and defibrillator devices, are associated with lower morbidity and are much less expensive

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Cleland JGF et al. (2003) Ongoing trials of cardiac resynchronisation Minerva Cardioangiol 51: 197–207

    CAS  PubMed  Google Scholar 

  2. Cleland JGF et al. (2001) Design and methodology of the CARE-HF trial: a randomised trial of cardiac resynchronisation in patients with heart failure and ventricular dyssynchrony Eur J Heart Fail 3: 481–489

    Article  CAS  Google Scholar 

  3. Freemantle N et al. (2003) Composite outcomes in randomized trials - greater precision but with greater uncertainty? JAMA 289: 2554–2559

    Article  Google Scholar 

  4. Cleland JGF et al. (2004) Clinical trials update and cumulative meta-analyses from the American College of Cardiology: WATCH, SCD-HeFT, DINAMIT, CASINO, INSPIRE, STRATUS-US, RIO-LIPIDS and cardiac resynchronisation therapy in heart failure Eur J Heart Fail 6: 501–508

    Article  Google Scholar 

  5. Cleland JGF et al. (2002) Outcome studies with device therapy in patients with heart failure J Cardiovasc Electrophysiol 13: S73–S91

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. University of Hull,

    John GF Cleland, Justin Ghosh & Nick Freemantle

  2. University of Hull,

    John GF Cleland, Justin Ghosh & Nick Freemantle

  3. University of Birmingham, UK

    John GF Cleland, Justin Ghosh & Nick Freemantle

Authors
  1. John GF Cleland
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Justin Ghosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nick Freemantle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John GF Cleland.

Ethics declarations

Competing interests

JGF Cleland is chairman of the Cardia Resynchronisation in heart Failure (CARE-HF) study which is sponsored by Medtronic and has received research support from Guidant and Medtronic.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cleland, J., Ghosh, J. & Freemantle, N. Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?. Nat Rev Cardiol 1, 10–11 (2004). https://doi.org/10.1038/ncpcardio0005

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0005

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing